apomorphine has been researched along with sk&f 75670 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Gerlach, J; Lublin, H; Peacock, L | 1 |
de Beltrán, KK; Kobayashi, M; Koshikawa, N; Omiya, K; Tomiyama, K | 1 |
Bone, RG; Villar, HO | 1 |
4 other study(ies) available for apomorphine and sk&f 75670
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Female; Grooming; Haloperidol; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome | 1992 |
Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Injections; Jaw; Male; Movement; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1990 |
Discriminating D1 and D2 agonists with a hydrophobic similarity index.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Apomorphine; Benzazepines; Chemical Phenomena; Chemistry, Physical; Chromans; Dopamine Agonists; Drug Design; Ergolines; Indoles; Ligands; Lisuride; Models, Molecular; Phenanthridines; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |